Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s stock price reached a new 52-week high during trading on Monday. The company traded as high as $225.25 and last traded at $225.14, with a volume of 126373 shares. The stock had previously closed at $216.50.

Wall Street Analysts Forecast Growth

NUTX has been the subject of several research reports. Wall Street Zen raised Nutex Health from a "hold" rating to a "buy" rating in a report on Saturday. B. Riley Financial restated a "buy" rating on shares of Nutex Health in a research note on Friday, September 4th. Lake Street Capital reaffirmed a "buy" rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Weiss Ratings upgraded Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, July 28th. Finally, Zacks Research raised Nutex Health from a "hold" rating to a "strong-buy" rating in a report on Monday, August 24th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $317.50.

Get Our Latest Report on Nutex Health

Nutex Health Stock Performance

The company's fifty day moving average is $188.64 and its 200 day moving average is $151.91. The company has a market capitalization of $1.54 billion, a P/E ratio of 8.83 and a beta of 0.55. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.95 by $4.43. The business had revenue of $210.75 million for the quarter, compared to analysts' expectations of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. As a group, equities analysts anticipate that Nutex Health Inc. will post 27.58 earnings per share for the current year.

Insider Buying and Selling at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the business's stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director directly owned 400 shares in the company, valued at approximately $85,700. The trade was a 33.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 44.68% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Corient Private Wealth LP purchased a new stake in shares of Nutex Health in the second quarter worth $1,142,000. Quantinno Capital Management LP purchased a new position in Nutex Health during the first quarter worth about $843,000. Empowered Funds LLC bought a new position in Nutex Health in the 2nd quarter worth about $7,720,000. Bank of New York Mellon Corp bought a new position in Nutex Health in the 2nd quarter worth about $3,956,000. Finally, First Trust Advisors LP raised its holdings in shares of Nutex Health by 60.0% in the 1st quarter. First Trust Advisors LP now owns 18,335 shares of the company's stock valued at $1,743,000 after acquiring an additional 6,874 shares in the last quarter. Hedge funds and other institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.

The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.

See Also

• Five stocks we like better than Nutex Health
• NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
• A Manufacturing Surprise Could Be a Big Win for These 2 Companies
• What a $1 Billion Chip Deal Says About Amazon's AI Ambitions
• 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here